Testosterone Replacement is Safe in Hypogonadal Men

Testosterone replacement therapy (TRT) is an effective means of restoring testosterone levels to normal in men who are unable to maintain serum levels on their own.   However, controversy surrounds TRT; the FDA has revisited the appropriateness of TRT and many private payers are putting up roadblocks to paying for it.   Certainly no one would argue to refrain from replacing thyroid hormone in patients who are hypothyroid or to refrain from administering insulin in insulin dependent diabetics, so how did TRT become so controversial?

TRT, until fairly recently was limited to injection therapy.  The medication has been available for decades and was relatively inexpensive and administration into the muscle was somewhat uncomfortable.    This may have served to constrain testosterone usage.

 

The popularity of TRT has taken off over the past several years due in large part to two related factors:

  1. The development of testosterone gels, a relatively easy and seemingly safe method of replacing testosterone in a manner which more closely approximates normal physiology.
  2. Marketing by Big Pharma direct to consumers using very effective advertising, leading to a tremendous increase in demand for these expensive gels over a fairly short period of time.

The surge in popularity was accompanied by additional research questioning whether there is any increase risk of myocardial infarction or other serious thrombotic events, particularly in elderly men.   Enough concern was raised that the FDA revised its guidelines for testosterone replacement.   Suddenly, advertisements from attorneys recommending patients sue their physicians for giving them TRT began to outnumber advertisements by Pharma promoting use of the medications.’

Study results

Good news for TRT users:   A retrospective study from Baylor colleges of Medicine in Houston by Ramasamy et al evaluated the records of 217 men aged 65 years and older.   153 were on TRT.   After a mean follow up f of 3.8 years,  the researchers observed no difference between the TRT and control groups in the occurrence of heart attack, coronary artery disease or pulmonary embolus.  In fact the control group had a significantly higher prevalence of death from any cause when compared to the TRT group.

As time passes, the reality of the consequences of TRT, both beneficial and, harmful (if any) will manifest.  Until that time, patients are best advised to perform TRT only under the direction of their physician.

You Might Also Enjoy...

Men Suffer From Hormone Imbalance Too

Hormone imbalance is often labeled as a women’s health issue. While it’s true that hormonal changes in menopause trigger notorious symptoms, men are at risk for hormone imbalance too. Learn more about low testosterone and how it can be treated.

What Is a Varicocele?

A varicocele is an enlarged vein in your scrotum, and it’s a leading cause of male infertility. Learn the signs and symptoms of varicoceles and what your treatment options are here.

What Are the Risks of Having a Vasectomy?

Hundreds of thousands of American men get vasectomies each year. It’s a popular and effective form of permanent birth control for men, but is it safe? Learn the possible risks of vasectomy and find out how you can reduce your risks here.

Can You Prevent Kidney Stones?

Kidney stones are common — and painful. Once you have one kidney stone, your risk of developing more increases. The good news is that there’s a lot you can do to lower your risk of kidney stone formation. Get our prevention tips here.

Recovering From a Vasectomy Reversal

Regretting your vasectomy? A vasectomy reversal could be the solution you’re seeking. It’s an outpatient procedure that can be up to 90% effective. Find out more about it and what to expect during recovery.

What Every Man Should Know About His Prostate

The prostate is a small gland in the male reproductive system. From how it functions to the importance of regular prostate screenings, find out what you need to know about your prostate health here.